SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals, Inc. – REGN
StockNews.AI • 596 days
Low Materiality0/10
Information
NEW YORK, June 30, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves...
Original sourceAI Summary
- Pomerantz LLP investigating securities fraud claims against Regeneron Pharmaceuticals, Inc. - U.S. Department of Justice filed a complaint against Regeneron for False Claims Act violation. - Regeneron's stock price fell approximately 3.36% following DOJ announcement. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Legal
Market-Moving
- Pomerantz LLP investigating securities fraud claims against Regeneron Pharmaceuticals, Inc.
- U.S. Department of Justice filed a complaint against Regeneron for False Claims Act violation.
- Regeneron's stock price fell approximately 3.36% following DOJ announcement.
Key Facts
- Pomerantz LLP investigating securities fraud claims against Regeneron Pharmaceuticals, Inc.
- U.S. Department of Justice filed a complaint against Regeneron for False Claims Act violation.
- Regeneron's stock price fell approximately 3.36% following DOJ announcement.